US › Healthcare

CDT Equity Inc. (CDT)

US · Healthcare · Biotechnology

$0.040.00%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$750.2M

Revenue YoY

+11.6%

Net profit

$68.5M

EPS

$-8.71

Net margin

9.1%

Key statistics

Market cap

$861,113

P/E

0.0

Forward P/E

0.0

P/B

0.00

Book value

$4,084.02

EPS (TTM)

$90,810.69

52-week high

$11.00

52-week low

$0.04

50-day MA

$7.45

200-day MA

$1,412.67

Beta

1.68

Shareholding

Insiders

38.25%

Institutions

0.01%

Largest institutional holders

Fund	Stake
Financial Management Professionals Inc	0.10%
Tower Research Capital LLC	0.09%
Morgan Stanley - Brokerage Accounts	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for CDT Equity Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.